NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $369,402 | -80.5% | 35,934 | -65.5% | 0.01% | -85.7% |
| Q3 2022 | $1,896,000 | -64.3% | 104,053 | +0.6% | 0.04% | -72.2% |
| Q2 2022 | $5,317,000 | -30.9% | 103,397 | -1.0% | 0.13% | -14.3% |
| Q1 2022 | $7,690,000 | -41.4% | 104,410 | +13.9% | 0.15% | -45.8% |
| Q4 2021 | $13,117,000 | +285.9% | 91,678 | +459.3% | 0.27% | +26.6% |
| Q3 2021 | $3,399,000 | -60.5% | 16,391 | -59.5% | 0.21% | +5.4% |
| Q2 2021 | $8,599,000 | +3638.7% | 40,510 | +3089.8% | 0.20% | +2155.6% |
| Q1 2021 | $230,000 | – | 1,270 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |